ID2 and GJB2 promote early-stage breast cancer progression by regulating cancer stemness
暂无分享,去创建一个
Abhishek Tyagi | Fei Xing | Shih-Ying Wu | Sambad Sharma | Kounosuke Watabe | Puspa R Pandey | Shih-Ying Wu | K. Watabe | Sambad Sharma | F. Xing | A. Chittiboyina | Yin Liu | Kerui Wu | Amar Chittiboyina | A. Tyagi | Yin Liu | Kerui Wu | P. Pandey
[1] J Cuzick,et al. Overview of the main outcomes in breast-cancer prevention trials , 2003, The Lancet.
[2] A. Iavarone,et al. Id family of helix-loop-helix proteins in cancer , 2005, Nature Reviews Cancer.
[3] P. Friedl,et al. Collective cell migration in morphogenesis, regeneration and cancer , 2009, Nature Reviews Molecular Cell Biology.
[4] J. Watkinson,et al. Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1 , 2010, BMC Medical Genomics.
[5] Fred R. Miller,et al. Malignant MCF10CA1 Cell Lines Derived from Premalignant Human Breast Epithelial MCF10AT Cells , 2004, Breast Cancer Research and Treatment.
[6] G. Landberg,et al. High ID2 protein expression correlates with a favourable prognosis in patients with primary breast cancer and reduces cellular invasiveness of breast cancer cells , 2005, International journal of cancer.
[7] J. Cuzick,et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial , 2010, The Lancet. Oncology.
[8] K. Miura,et al. The Drg-1 gene suppresses tumor metastasis in prostate cancer. , 2003, Cancer research.
[9] Dhara N. Amin,et al. Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F. , 2010, Cancer research.
[10] Xin Hu,et al. ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expression , 2014, OncoTargets and therapy.
[11] H. Burger,et al. Inhibin: definition and nomenclature, including related substances. , 1988, The Journal of clinical endocrinology and metabolism.
[12] Sean Davis,et al. Molecular Grading of Ductal Carcinoma In situ of the Breast , 2008, Clinical Cancer Research.
[13] B. Hogan,et al. The Id2+ distal tip lung epithelium contains individual multipotent embryonic progenitor cells , 2009, Development.
[14] M. Thun,et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. , 2009, The Lancet. Oncology.
[15] Jun Xia,et al. Upregulated INHBA expression is associated with poor survival in gastric cancer , 2012, Medical Oncology.
[16] J. Hopper,et al. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. , 1999, The Journal of clinical endocrinology and metabolism.
[17] E. D. de Vries,et al. Granulosa cell tumors of the ovary: the clinical value of serum inhibin A and B levels in a large single center cohort. , 2007, Gynecologic oncology.
[18] Wei Zhang,et al. Genome-scale analysis identifies GJB2 and ERO1LB as prognosis markers in patients with pancreatic cancer , 2017, Oncotarget.
[19] Enrique Lerma,et al. ASPN and GJB2 Are Implicated in the Mechanisms of Invasion of Ductal Breast Carcinomas , 2012, Journal of Cancer.
[20] K. Mimori,et al. Significance of INHBA expression in human colorectal cancer. , 2013, Oncology reports.
[21] S. Friedman,et al. BMP-7 opposes TGF-beta1-mediated collagen induction in mouse pulmonary myofibroblasts through Id2. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[22] M. Monden,et al. Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation. , 2005, International journal of oncology.
[23] L. Poellinger,et al. Induction of ID2 Expression by Hypoxia-inducible Factor-1 , 2004, Journal of Biological Chemistry.
[24] Ofer Reizes,et al. Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase , 2018, Nature Communications.
[25] S. Becker-Herman,et al. Id2 Negatively Regulates B Cell Differentiation in the Spleen1 , 2002, The Journal of Immunology.
[26] P. Kolatkar,et al. A Divalent Ion Is Crucial in the Structure and Dominant-Negative Function of ID Proteins, a Class of Helix-Loop-Helix Transcription Regulators , 2012, PloS one.
[27] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[28] Y. Itahana,et al. Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells. , 2003, Cancer research.
[29] F. Miller,et al. MCF10AT: a model for the evolution of cancer from proliferative breast disease. , 1996, The American journal of pathology.
[30] A. Donfrancesco,et al. Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma. , 2002, Cancer research.
[31] T. Klonisch,et al. Inhibitor of DNA Binding 2 Inhibits Epithelial-Mesenchymal Transition via Up-Regulation of Notch3 in Breast Cancer , 2018, Translational oncology.
[32] C. Glackin,et al. TWIST Family of Basic Helix‐Loop‐Helix Transcription Factors Mediate Human Mesenchymal Stem Cell Growth and Commitment , 2009, Stem cells.
[33] D. Robertson,et al. Inhibin as a diagnostic marker for ovarian cancer. , 2007, Cancer letters.
[34] M. Monden,et al. Aberrant Expression of Connexin 26 Is Associated with Lung Metastasis of Colorectal Cancer , 2008, Clinical Cancer Research.
[35] H. Friess,et al. The helix-loop-helix protein Id2 is overexpressed in human pancreatic cancer. , 1998, Cancer research.
[36] C K Redmond,et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.
[37] F. Miller,et al. MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. , 2000, Journal of the National Cancer Institute.
[38] T. Julian,et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. , 2011, Journal of the National Cancer Institute.
[39] J. Massagué,et al. Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer , 2016, Nature.